Cosson, A
Chapiro, E
Bougacha, N
Lambert, J
Herbi, L
Cung, H-A
Algrin, C
Keren, B
Damm, F
Gabillaud, C
Brunelle-Navas, M-N
Davi, F
Merle-BĂ©ral, H
Le Garff-Tavernier, M
Roos-Weil, D
Choquet, S
Uzunov, M
Morel, V
Leblond, V
Maloum, K
Lepretre, S
Feugier, P
Lesty, C
Lejeune, J
Sutton, L
Landesman, Y
Susin, S A
Nguyen-Khac, F
Article History
First Online: 27 March 2017
Competing interests
: YL is an employee of Karyopharm Therapeutics Inc. and receives compensation, and holds equity in the company. The remaining authors declare no conflict of interest.